目的研发指南解读类文献的报告规范,以期更好地帮助指南解读者报告指南重要信息。方法RIGHT for INT课题组参考EQUATOR网站推荐的报告规范制订方法,确定了3个阶段的制订流程:第一阶段,通过邮件和微信的途径招募多学科的专家,根据职能划...目的研发指南解读类文献的报告规范,以期更好地帮助指南解读者报告指南重要信息。方法RIGHT for INT课题组参考EQUATOR网站推荐的报告规范制订方法,确定了3个阶段的制订流程:第一阶段,通过邮件和微信的途径招募多学科的专家,根据职能划分成核心制订小组、共识专家组及秘书组3个小组;第二阶段,采用文献调研和头脑风暴的方法收集初始条目;第三阶段,通过德尔菲调查和专家意见咨询,形成最终的RIGHT for INT清单。结果通过核心小组头脑风暴讨论和文献回顾,共收集40个初始条目。经过德尔菲调查和专家意见咨询过程(两轮均为17位专家,回复率均为100%),最终形成27个条目的RIGHT for INT清单。结论RIGHT for INT报告清单为指南解读者提供了撰写指南解读类文章的详细指导。展开更多
Background:Chinese patent medicine(CPM)is a type of traditional Chinese medicine(TCM)that utilizes Chi-nese medicinal materials as its raw ingredients.Following the principles of TCM theory,it undergoes specific proce...Background:Chinese patent medicine(CPM)is a type of traditional Chinese medicine(TCM)that utilizes Chi-nese medicinal materials as its raw ingredients.Following the principles of TCM theory,it undergoes specific processing techniques to create various dosage forms for the prevention and treatment of diseases.The current CPM guidelines,both domestically and internationally,are constrained by limitations in methodological quality and reporting,which do not adequately address the requirements of the majority of clinicians and patients.Objective:To evaluate the methodological rigor and reporting quality of clinical practice guidelines(CPGs)in CPM,with aim to assess their current quality and to provide recommendations for improving guideline develop-ment.Methods:The study utilized the Appraisal of Guidelines for Research and Evaluation II(AGREE II)tool and the Reporting Items for Practice Guidelines in Healthcare for Traditional Chinese Medicine(RIGHT for TCM)checklist to evaluate the methodological rigor and reporting quality of CPM guidelines.After the training session,the four investigators were divided into two groups to evaluate the guidelines of patent Chinese medicine included in this study based on the aforementioned criteria.In case of any discrepancies,a secondary analysis was conducted by all four researchers under the guidance of two clinical experts,ensuring an impartial evaluation outcome.Average score or average reporting rate were calculated for each domain.Results:A total of 32 CPM guidelines that met the inclusion criteria were analyzed.The AGREE II yielded an average score of 67.2%.The domain scores were as follows:scope and purpose(93.3%),stakeholder involve-ment(50.1%),rigor of development(76.8%),clarity of presentation(79.4%),applicability(40.1%),and editorial independence(63.6%).The average reporting rate of the RIGHT for TCM checklist was 70.0%,with the report-ing rates for the seven domains as follows:basic information(94.2%),background(87.9%),evidence(97.5%),recommendation(57.5%),review and quality assurance(11.4%),funding and declaration and management of interests(26.6%),and other information(68.8%).Conclusions:The methodological and reporting quality of CPGs for CPM have been deemed acceptable since 2020.However,there is still room for improvement,particularly in enhancing the reporting quality to provide clinicians and patients with more effective and comprehensive guidance.Additionally,it may be beneficial to develop a comprehensive reporting checklist specifically tailored for CPM guideline development.展开更多
文摘目的研发指南解读类文献的报告规范,以期更好地帮助指南解读者报告指南重要信息。方法RIGHT for INT课题组参考EQUATOR网站推荐的报告规范制订方法,确定了3个阶段的制订流程:第一阶段,通过邮件和微信的途径招募多学科的专家,根据职能划分成核心制订小组、共识专家组及秘书组3个小组;第二阶段,采用文献调研和头脑风暴的方法收集初始条目;第三阶段,通过德尔菲调查和专家意见咨询,形成最终的RIGHT for INT清单。结果通过核心小组头脑风暴讨论和文献回顾,共收集40个初始条目。经过德尔菲调查和专家意见咨询过程(两轮均为17位专家,回复率均为100%),最终形成27个条目的RIGHT for INT清单。结论RIGHT for INT报告清单为指南解读者提供了撰写指南解读类文章的详细指导。
基金supported by China Association of Chinese Medicine[grant number 2022-QNRC2-A10]Department of Science and Technology of Zhejiang Province[grant number 2023C03040].
文摘Background:Chinese patent medicine(CPM)is a type of traditional Chinese medicine(TCM)that utilizes Chi-nese medicinal materials as its raw ingredients.Following the principles of TCM theory,it undergoes specific processing techniques to create various dosage forms for the prevention and treatment of diseases.The current CPM guidelines,both domestically and internationally,are constrained by limitations in methodological quality and reporting,which do not adequately address the requirements of the majority of clinicians and patients.Objective:To evaluate the methodological rigor and reporting quality of clinical practice guidelines(CPGs)in CPM,with aim to assess their current quality and to provide recommendations for improving guideline develop-ment.Methods:The study utilized the Appraisal of Guidelines for Research and Evaluation II(AGREE II)tool and the Reporting Items for Practice Guidelines in Healthcare for Traditional Chinese Medicine(RIGHT for TCM)checklist to evaluate the methodological rigor and reporting quality of CPM guidelines.After the training session,the four investigators were divided into two groups to evaluate the guidelines of patent Chinese medicine included in this study based on the aforementioned criteria.In case of any discrepancies,a secondary analysis was conducted by all four researchers under the guidance of two clinical experts,ensuring an impartial evaluation outcome.Average score or average reporting rate were calculated for each domain.Results:A total of 32 CPM guidelines that met the inclusion criteria were analyzed.The AGREE II yielded an average score of 67.2%.The domain scores were as follows:scope and purpose(93.3%),stakeholder involve-ment(50.1%),rigor of development(76.8%),clarity of presentation(79.4%),applicability(40.1%),and editorial independence(63.6%).The average reporting rate of the RIGHT for TCM checklist was 70.0%,with the report-ing rates for the seven domains as follows:basic information(94.2%),background(87.9%),evidence(97.5%),recommendation(57.5%),review and quality assurance(11.4%),funding and declaration and management of interests(26.6%),and other information(68.8%).Conclusions:The methodological and reporting quality of CPGs for CPM have been deemed acceptable since 2020.However,there is still room for improvement,particularly in enhancing the reporting quality to provide clinicians and patients with more effective and comprehensive guidance.Additionally,it may be beneficial to develop a comprehensive reporting checklist specifically tailored for CPM guideline development.
